FI820699L - Pyridazinoner foerfarande foer deras framstaellning dessa foereningar innehaollande farmaceutiska preparat och deras anvaendning - Google Patents
Pyridazinoner foerfarande foer deras framstaellning dessa foereningar innehaollande farmaceutiska preparat och deras anvaendningInfo
- Publication number
- FI820699L FI820699L FI820699A FI820699A FI820699L FI 820699 L FI820699 L FI 820699L FI 820699 A FI820699 A FI 820699A FI 820699 A FI820699 A FI 820699A FI 820699 L FI820699 L FI 820699L
- Authority
- FI
- Finland
- Prior art keywords
- deras
- pyridazinoner
- pharmaceutical preparation
- foerfarande foer
- anvaendning
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- -1 amino, acetylamino, methyl Chemical group 0.000 abstract 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000002785 anti-thrombosis Effects 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 229910052740 iodine Chemical group 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Treating Waste Gases (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH144381 | 1981-03-04 | ||
CH144381 | 1981-03-04 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI820699L true FI820699L (fi) | 1982-09-05 |
FI72718B FI72718B (fi) | 1987-03-31 |
FI72718C FI72718C (fi) | 1987-07-10 |
Family
ID=4210578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI820699A FI72718C (fi) | 1981-03-04 | 1982-02-26 | Foerfarande foer framstaellning av terapeutiskt verkande, substituerade 6-(4-morfolino-fenyl)-4,5-dihydro- 3(2h)-pyridazinoner och deras syraadditionssalter. |
Country Status (24)
Country | Link |
---|---|
US (3) | US4613599A (fi) |
EP (1) | EP0059688B1 (fi) |
JP (1) | JPS57158762A (fi) |
AT (1) | ATE13294T1 (fi) |
AU (1) | AU558039B2 (fi) |
CA (1) | CA1180703A (fi) |
CY (1) | CY1396A (fi) |
DD (1) | DD209461A5 (fi) |
DE (1) | DE3263497D1 (fi) |
DK (1) | DK148772C (fi) |
ES (4) | ES510055A0 (fi) |
FI (1) | FI72718C (fi) |
GB (1) | GB2094302B (fi) |
GR (1) | GR81397B (fi) |
HK (1) | HK87687A (fi) |
HU (1) | HU191083B (fi) |
IE (1) | IE52672B1 (fi) |
IL (1) | IL65161A (fi) |
MY (1) | MY8700736A (fi) |
NO (1) | NO158135C (fi) |
NZ (1) | NZ199892A (fi) |
PT (1) | PT74520B (fi) |
SG (1) | SG59587G (fi) |
ZA (1) | ZA821397B (fi) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4734415A (en) * | 1982-08-13 | 1988-03-29 | Warner-Lambert Company | Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2H)-pyridazinones and 6-(substituted) phenyl-3(2H)-pyridazinones |
GB8400863D0 (en) * | 1984-01-13 | 1984-02-15 | Smith Kline French Lab | Chemical compounds |
GB8426804D0 (en) * | 1984-10-23 | 1984-11-28 | Ciba Geigy Ag | Pyridazinones preparations |
JPS61158969A (ja) * | 1984-12-24 | 1986-07-18 | ワーナー‐ランバート・コンパニー | 4,5‐ジヒドロ‐4,4‐ジアルキル‐6‐(置換)フエニル‐3(2h)‐ピリダジノン類 |
IL79280A (en) * | 1985-07-05 | 1990-07-12 | Smith Kline French Lab | 4-(6-oxo-dihydro or tetrahydropyridazin-3-yl)benzene derivatives,their preparation and pharmaceutical compositions containing them |
US4970210A (en) * | 1987-07-17 | 1990-11-13 | Abbott Laboratories | Triazinone lipoxygenase compounds |
DE3735207A1 (de) * | 1987-10-17 | 1989-04-27 | Basf Ag | Mittel auf der basis von phenylpyridazinon-derivaten zur wachstumsfoerderung und fettreduktion bei tieren |
US9890127B2 (en) * | 2013-03-11 | 2018-02-13 | The Broad Institute, Inc. | Compounds and compositions for the treatment of cancer |
EP3661917B1 (en) | 2017-08-04 | 2022-05-11 | Bayer Aktiengesellschaft | 6-((3-trifluoromethyl)phenyl)-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating cancer |
JOP20200024A1 (ar) | 2017-08-04 | 2020-02-02 | Bayer Ag | مركبات ثنائي هيدروكساديازينون |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1488330A (en) * | 1923-02-01 | 1924-03-25 | Everitt James | Clothes-hanging bar formed of hinged-together members |
IL37788A0 (en) * | 1970-10-09 | 1971-12-29 | American Cyanamid Co | New pyridazinone compounds,their preparation and pharmaceutical compositions containing them |
GB1383906A (en) * | 1971-02-22 | 1974-02-12 | Bdh Pharmaceuticals Ltd | Pyridazinones |
US3975388A (en) * | 1971-02-22 | 1976-08-17 | Bdh Pharmaceuticals Limited | Pyridazinones |
GB1488330A (en) * | 1973-12-19 | 1977-10-12 | Smith Kline French Lab | Dihydropyridazinones |
DE2854191A1 (de) * | 1978-12-15 | 1980-07-03 | Basf Ag | Dihydropyridazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel |
-
1982
- 1982-02-26 EP EP82810090A patent/EP0059688B1/de not_active Expired
- 1982-02-26 DE DE8282810090T patent/DE3263497D1/de not_active Expired
- 1982-02-26 AT AT82810090T patent/ATE13294T1/de active
- 1982-02-26 FI FI820699A patent/FI72718C/fi not_active IP Right Cessation
- 1982-03-02 CA CA000397433A patent/CA1180703A/en not_active Expired
- 1982-03-02 GB GB8205989A patent/GB2094302B/en not_active Expired
- 1982-03-02 CY CY139682A patent/CY1396A/xx unknown
- 1982-03-02 GR GR67459A patent/GR81397B/el unknown
- 1982-03-02 ES ES510055A patent/ES510055A0/es active Granted
- 1982-03-03 NZ NZ199892A patent/NZ199892A/en unknown
- 1982-03-03 PT PT74520A patent/PT74520B/pt unknown
- 1982-03-03 ZA ZA821397A patent/ZA821397B/xx unknown
- 1982-03-03 IL IL65161A patent/IL65161A/xx unknown
- 1982-03-03 NO NO820670A patent/NO158135C/no unknown
- 1982-03-03 IE IE478/82A patent/IE52672B1/en unknown
- 1982-03-03 DK DK91782A patent/DK148772C/da not_active IP Right Cessation
- 1982-03-03 AU AU81065/82A patent/AU558039B2/en not_active Ceased
- 1982-03-03 HU HU82652A patent/HU191083B/hu unknown
- 1982-03-03 DD DD82237856A patent/DD209461A5/de unknown
- 1982-03-04 JP JP57033169A patent/JPS57158762A/ja active Pending
-
1983
- 1983-02-23 ES ES520022A patent/ES8403892A1/es not_active Expired
- 1983-02-23 ES ES520023A patent/ES8403893A1/es not_active Expired
- 1983-02-23 ES ES520024A patent/ES520024A0/es active Granted
-
1985
- 1985-07-24 US US06/758,833 patent/US4613599A/en not_active Expired - Fee Related
-
1986
- 1986-05-05 US US06/859,684 patent/US4654340A/en not_active Expired - Fee Related
- 1986-11-28 US US06/935,901 patent/US4704391A/en not_active Expired - Fee Related
-
1987
- 1987-07-22 SG SG595/87A patent/SG59587G/en unknown
- 1987-11-26 HK HK876/87A patent/HK87687A/xx unknown
- 1987-12-30 MY MY736/87A patent/MY8700736A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI820699L (fi) | Pyridazinoner foerfarande foer deras framstaellning dessa foereningar innehaollande farmaceutiska preparat och deras anvaendning | |
IT8103385A0 (it) | Procedimento per la preparazione dell'acido 2-(6-metossi-2-naftil)propionico | |
ES543368A0 (es) | Procedimiento para la obtencion de derivados de 1-fluoro-1- -azolil-2,2-diaril-etano | |
ES476408A1 (es) | Un procedimiento de preparacion de derivados de 2,4-tiazoli-dindiona. | |
DK154979C (da) | Analogifremgangsmaade til fremstilling af phenethanolaminderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
JPS56156273A (en) | Acetic derivative | |
SE8200309L (sv) | Guanidinocyklohexankarboxylsyraderivat | |
JPS53135958A (en) | Substituted phenylacetic acid derivatives and their preparation | |
DE3566666D1 (en) | Substituted pyridazinones, method for their preparation, pharmaceutical preparation containing these compounds and their use | |
IL61769A0 (en) | 2-phenylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them | |
JPS5687573A (en) | 2-aryl-3-acylthiazolidine derivative | |
JPS5598171A (en) | 5-fluorouracil derivative and its preparation | |
IT1191159B (it) | Procedimento per la preparazione di derivati eterociclici dell'acido acetico | |
JPS56127347A (en) | Preparation of 2-substituted imino-3,3-di-substituted-4- halobutyric acid derivative | |
IT8322098A0 (it) | Procedimento per la preparazione dell'acido 2-(6-metossinaft-2-il)propionico. | |
IT8219944A0 (it) | Procedimento per preparare sali di addizione di acidi di 3,4-diacilossi-alfa-parentesi aperta (metilammino)-metilparentesi quadra chiusa -benzilalcool. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |
Owner name: CIBA-GEIGY AG |